Talk:Remdesivir
| Please place new discussions at the bottom of the talk page. |
| This is the talk page for discussing improvements to the Remdesivir article. This is not a forum for general discussion of the article's subject. |
Article policies
|
| Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL |
Archives: 1Auto-archiving period: 14 days  |
 | The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page. |
 | This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
.svg){kind=small}
 | This article has been viewed enough times in a single week to appear in the Top 25 Report 2 times. The weeks in which this happened: |
 | Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Remdesivir.
|
A little late here but,
editI was surprised reading this article that there was very little mention of any of the past criticism of this drug. It sounds like it has had a lot of supporters and detractors since 2020, yet there is very little mention of any of the previous criticism (a couple sentences from what I read). The WHO recently walked back their criticism of the drug WHO recommends against the use of remdesivir in COVID-19 patients
And another recent article supports its use, along with the trials that WHO cites "Study Supports Use of Remdesivir for COVID-19 Patients on Low-Flow Oxygen or No Oxygen (hopkinsmedicine.org)"
So my question is: if the general scientific consensus has agreed that Remdesivir does work, does that mean there is little need of much discussion on any previous detractions or concerns about its quick approval? I would be of the opinion that the FDA not convening outside panels for this drug is notable, but I would like to know what this articles frequent editors think. (more sources: forbes and science.org) 134.134.139.84 (talk) 18:57, 11 October 2023 (UTC)
- Any good sources giving an overview? So far as I can see the modern view is that remdesevir is a bit rubbish for COVID.[1] Bon courage (talk) 19:14, 11 October 2023 (UTC)
Semi-protected edit request on 28 January 2024
edit | This edit request has been answered. Set the |answered= or |ans= parameter to no to reactivate your request. |
Possible side effects include death. 73.121.109.117 (talk) 11:52, 28 January 2024 (UTC)
Not done No source. Bon courage (talk) 12:06, 28 January 2024 (UTC)
Deletion of sourced material
editHi @Smokefoot: I would appreciate it if you could please double-check your edit, as it removed a significant amount of sourced material, most of which was unrelated to patents. Thanks, Boghog (talk) 12:11, 6 October 2024 (UTC)